Stryker Warns of Order and Manufacturing Disruptions Post-Cyberattack

• The cyberattack is disrupting Stryker's ability to process orders, manufacture products, and ship to customers, with full financial impact still unknown
• Handala, an Iranian-linked hacking group, claimed the attack as retaliation for U.S.-Israeli strikes on a school in Minab, Iran
• Patient-related services and connected medical devices have not been affected by the incident, and the company's investigation is ongoing

Summary: Stryker Cyberattack Causes Major Business Disruptions

Key Developments:

Medical device manufacturer Stryker disclosed on March 12 that a cyberattack on its computer systems is causing widespread operational disruptions, affecting its ability to process orders, manufacture products, and ship to customers. The attack occurred on March 11.

Attribution and Motive:

An Iranian-linked hacking group called Handala claimed responsibility for the cyberattack, stating it was retaliation for a strike on a girls' school in Minab, southern Iran. According to Iran's U.N. ambassador in Geneva, the school attack—which occurred during the first day of U.S.-Israeli strikes on Iran—killed an estimated 150 students, though Reuters has not independently verified this figure.

Company Impact:

Stryker, which employs 56,000 people across operations in 61 countries, confirmed that:

• Order processing, manufacturing, and shipping capabilities are significantly disrupted
• Patient-related services and connected medical products remain unaffected
• The full scale and financial impact are currently unknown
• Investigation is ongoing

Market Implications:

The incident highlights escalating geopolitical cyber risks affecting major U.S. healthcare companies. The attack's disruption to a critical medical device supplier could have ripple effects across healthcare supply chains. Investors should monitor for potential revenue impacts and insurance claims in upcoming earnings reports.

The cyberattack underscores growing vulnerabilities in the medical technology sector to nation-state actors, potentially affecting investor sentiment toward healthcare equipment manufacturers with global operations.